Get started
Author

E. Piazza

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
2003 · C. Gridelli, F. Perrone, et al. · JNCI Journal of the National Cancer Institute · 785
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
2004 · M Di Maio, C Gridelli, et al. · British Journal of Cancer · 130
PDF
Pharmacokinetics of VP16-213 given by different administration methods
1982 · M. D'Incalci, P. Farina, et al. · Cancer Chemotherapy and Pharmacology · 120
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
1999 · S Cascinu, R R Silva, et al. · British Journal of Cancer · 83
PDF
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses
2000 · C Gridelli, L Frontini, et al. · British Journal of Cancer · 60
PDF
Transient blindness and seizure associated with cisplantin therapy
1988 · M. T. Cattaneo, V. Filipazzi, et al. · Journal of Cancer Research and Clinical Oncology · 38
Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.
1980 · E Piazza, M G Donelli, et al. · PubMed · 34
High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study
1997 · R. Labianca, S. Cascinu, et al. · Annals of Oncology · 29
PDF
Ceravolo
2004 · M. Cantore, G. Fiorentini, et al. · Journal of Chemotherapy · 25
Supportive care in patients with advanced non-small-cell lung cancer
2003 · M Di Maio, F Perrone, et al. · British Journal of Cancer · 23
PDF
Pharmacokinetic study of intravenous and oral idarubicin in cancer patients.
1987 · V Tamassia, M A Pacciarini, et al. · PubMed · 20
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study
2000 · A. Sobrero, A. Zaniboni, et al. · Annals of Oncology · 17
PDF
Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients.
1984 · A Martini, E Moro, et al. · PubMed · 17
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
2021 · Gerardo Rosati, Sara Lonardi, et al. · European Journal of Cancer · 16
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
2003 · M Cantore, G Fiorentini, et al. · PubMed · 12
Differential pulse polarographic determination of BCNU pharmacokinetics in patients with lung cancer.
1981 · R Russo, I Bartosek, et al. · PubMed · 11
A serological study of the cell fractions during the embryonic development of liver in chick
1963 · V. D'Amelio, V. Mutolo, et al. · Experimental Cell Research · 10
Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit
1981 · E. Piazza, M. Broggini, et al. · European Journal of Cancer and Clinical Oncology · 9
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience
1994 · R. Labianca, G. Giaccon, et al. · European Journal of Cancer · 7
Microsomal antigens in developing chick liver
1965 · V. Mutolo, V. D'Amelio, et al. · Experimental Cell Research · 7
VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinoma
1982 · L. Morasca, S. Marsoni, et al. · Cancer Chemotherapy and Pharmacology · 6
Single-Agent Epirubicin as Primary Chemotherapy in T2–T3, N0–N2, M0 Breast Carcinoma: 6-Year Follow-Up
2004 · S. Barni, E. Piazza, et al. · Oncology · 5
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.
1980 · L Ottolenghi, L Morasca, et al. · PubMed · 4
Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies
2017 · A. Morabito, L. Cavanna, et al. · Annals of Oncology · 3
Single-day regimen of palonosetron (PALO) and dexamethasone (DEX) for the prevention of emesis associated with moderately emetogenic chemotherapy (MEC): Subgroup analysis from a randomized phase III trial
2009 · L. Celio, E. Bajetta, et al. · Journal of Clinical Oncology · 3
Works count: 59
Citation count: 1,491
H-index: 14
I10-index: 17
Year
Topic
Type